- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 189-203 of
231 results
2022 Exhibit: Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, A...
Document
IPR2022-00853, No. 2022-66 Exhibit - Holly Auer, Penn Medicine Immunotherapy Pioneer Carl June, MD, Awarded 2015 Paul Ehrlich and Ludwig Darmstaedter Prize, PENN TODAY Mar 11, 201...
|
|
Cite Document
2041 Exhibit: Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Syste...
Document
IPR2022-00853, No. 2041-85 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2...
|
|
Cite Document
2010 Exhibit: Barbara Savoldo et al, CD28 costimulation improves expansion and p...
Document
IPR2022-00853, No. 2010-54 Exhibit - Barbara Savoldo et al, CD28 costimulation improves expansion and persistence of chimeric antigen receptor modified T cells in lymphoma patients, 121 J C...
|
|
Cite Document
2006 Exhibit: Denise Grady, FDA Approves First Gene Altering Leukemia Treatmen...
Document
IPR2022-00853, No. 2006-50 Exhibit - Denise Grady, FDA Approves First Gene Altering Leukemia Treatment, Costing $475,000, NY TIMES Aug 30, 2017, httpswwwnytimescom20170830health...
|
|
Cite Document
2020 Exhibit: James N Kochenderfer et al, B cell depletion and remissions of malign...
Document
IPR2022-00853, No. 2020-64 Exhibit - James N Kochenderfer et al, B cell depletion and remissions of malignancy along with cytokine associated toxicity in a clinical trial of anti CD 19 chimeric an...
|
|
Cite Document
2021 Exhibit: Carl June Named One of Time���s 100 Most Influential People in the W...
Document
IPR2022-00853, No. 2021-65 Exhibit - Carl June Named One of Time���s 100 Most Influential People in the World, PENN MEDICINE Apr 26, 2018, httpspathologymedupennedunewscarl june nam...
|
|
Cite Document
2043 Exhibit: Cancer treatment myths Any truth to these common beliefs, MAYO C...
Document
IPR2022-00853, No. 2043-87 Exhibit - Cancer treatment myths Any truth to these common beliefs, MAYO CLINIC March 22, 2022, httpswwwmayoclinicorgdiseases conditionscancerin depthcan...
|
|
Cite Document
2017 Exhibit: David L Porter et al, Chimeric Antigen Receptor Modified T Cells Direc...
Document
IPR2022-00853, No. 2017-61 Exhibit - David L Porter et al, Chimeric Antigen Receptor Modified T Cells Directed Against CD 19 CTL0l 9 cells Have Long Term Persistence And Induce Durable Re...
|
|
Cite Document
2024 Exhibit: 2015 Watanabe Award Winner Carl H June, IND CLINICAL AND TRAN...
Document
IPR2022-00853, No. 2024-68 Exhibit - 2015 Watanabe Award Winner Carl H June, IND CLINICAL AND TRANSLATIONAL SCIS INST, httpsindianactsiorgawardswatanabe award winners2015 wat...
|
|
Cite Document
2029 Exhibit: Pilot Study for Patients with Chemotherapy Resistant or Refractory C...
Document
IPR2022-00853, No. 2029-73 Exhibit - Pilot Study for Patients with Chemotherapy Resistant or Refractory CD19 Leukemia and Lymphoma CART 19, CLINICALTRIALSGOV April 29, 2009, httpwe...
|
|
Cite Document
2046 Exhibit: AAI Steinman Award for Human Immunology Research Past Recipien...
Document
IPR2022-00853, No. 2046-90 Exhibit - AAI Steinman Award for Human Immunology Research Past Recipients, AM ASS���N OF IMMUNOLOGISTS, httpswwwaaiorgAwardsCareer AwardsAAI Ste...
|
|
Cite Document
2025 Exhibit: Agilent Presents Thought Leader Award to Drs Carl H June and Micha...
Document
IPR2022-00853, No. 2025-69 Exhibit - Agilent Presents Thought Leader Award to Drs Carl H June and Michael Milone, AGILENT TECHS INC Nov 17, 2020, httpswwwagilentcomaboutnewsroomp...
|
|
Cite Document
2007 Exhibit: FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE TH...
Document
IPR2022-00853, No. 2007-51 Exhibit - FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE THERAPY TO THE UNITED STATES Aug 30, 2017, httpswwwfdagovnews eventspress ...
|
|
Cite Document
2035 Exhibit: Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CA...
Document
IPR2022-00853, No. 2035-79 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHER...
|
|
Cite Document
2006 Exhibit: Denise Grady, FDA Approves First Gene Altering Leukemia Treatmen...
Document
IPR2022-00853, No. 2006-50 Exhibit - Denise Grady, FDA Approves First Gene Altering Leukemia Treatment, Costing $475,000, NY TIMES Aug 30, 2017, httpswwwnytimescom20170830health...
|
|
Cite Document
